MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
- Conditions
- TraumaAdult Stem Cells
- Interventions
- Biological: MultiStemBiological: Placebo
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 156
- Registration Number
- NCT04533464
- Locations
- 🇺🇸
Healios Investigational Site, Houston, Texas, United States
MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)
- Conditions
- ARDS
- Interventions
- Biological: MultiStemBiological: Placebo
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 400
- Registration Number
- NCT04367077
- Locations
- 🇺🇸
Athersys Investigational Site 107, Chicago, Illinois, United States
🇺🇸Athersys Investigational Site 103, Akron, Ohio, United States
🇺🇸Athersys Investigational Site 101, Cleveland, Ohio, United States
Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome
- Conditions
- Respiratory Distress Syndrome, Adult
- Interventions
- Biological: HLCM051
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 35
- Registration Number
- NCT03807804
- Locations
- 🇯🇵
Investigational Site Number 025, Yokohama, Kanagawa, Japan
🇯🇵Investigational Site Number 029, Yokohama, Kanagawa, Japan
🇯🇵Investigational Site Number 018, Kashihara, Nara, Japan
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
- Conditions
- Ischemic Stroke
- Interventions
- Biological: PlaceboBiological: MultiStem
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 300
- Registration Number
- NCT03545607
- Locations
- 🇺🇸
Athersys Investigational Site 104, Cleveland, Ohio, United States
🇺🇸Athersys Investigational Site 129, Clearwater, Florida, United States
🇺🇸Athersys Investigational Site 121, Chicago, Illinois, United States
Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements
- Conditions
- Stroke, Acute
- Interventions
- Biological: HLCM051Biological: Placebo
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 206
- Registration Number
- NCT02961504
- Locations
- 🇯🇵
Hokkaido University Hospital, Sapporo, Japan
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Biological: MultiStemBiological: Placebo
- First Posted Date
- 2015-11-23
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 36
- Registration Number
- NCT02611609
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇬🇧St. Georges Hospital, London, United Kingdom
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
- Conditions
- Heart AttackNSTEMI
- Interventions
- Biological: AMI MultiStem cellsOther: Sham
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 34
- Registration Number
- NCT02277613
Study to Examine the Effects of MultiStem in Ischemic Stroke
- Conditions
- Ischemic Stroke
- Interventions
- Biological: MultiStemBiological: Placebo
- First Posted Date
- 2011-09-19
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 134
- Registration Number
- NCT01436487
- Locations
- 🇺🇸
Summa Health System, Akron, Ohio, United States
🇺🇸Palmetto Health Richland, Columbia, South Carolina, United States
🇺🇸MetroHealth Medical Center, Cleveland, Ohio, United States
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Healios K.K.
- Registration Number
- NCT00735683
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia
- Conditions
- Hematologic Malignancies
- Interventions
- Biological: MultiStem®
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Healios K.K.
- Target Recruit Count
- 36
- Registration Number
- NCT00677859
- Locations
- 🇺🇸
Mayo Clinic Hospital, Phoenix, Arizona, United States
🇺🇸Oregon State University Medical Center, Portland, Oregon, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States